Axon Enterprise: Barclays cuts target price to $507 from $688
AXON•Barclays cut its target price for Axon Enterprise to $507 from $688.
Related News
Aptevo reports tumor-cell killing under immunosuppressive conditions in preclinical studies
APVO•
Ferguson Enterprises Q3 adjusted diluted EPS rises 8% to $3.43
FERG•
OneMedNet year-to-date contracted bookings reach $18.76 million
ONMD•
LSI Industries Inc.: Oppenheimer cuts target price to $27 from $29
LYTS•
Lexicon's sotagliflozin reduces clot formation in small healthy-volunteer study
LXRX•